Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement.

Abstract:

:Sixty-five patients with hairy cell leukemia underwent splenectomy; 27 had a complete remission as defined by a return in WBC, RBC, and platelet counts to a defined level, and 38 had a partial remission with a return of only one or two of these parameters to the defined level. The 5-yr actuarial survival for all patients is 68%; for CR patients it is 76%, and for PR patients 62%. The response to splenectomy did not correlate with the spleen weight. Seventeen patients had a postsplenectomy platelet count of less than 200 x 10(9)/liter, and 34 patients had a postsplenectomy platelet count of 200 x 10(9)/liter or greater. A presplenectomy bone core biopsy hairy cell index (HCI) was calculated by multiplying the percent marrow cellularity by the percent of hairy cells in the marrow for 51 patients. The difference in the mean HCI between the two platelet response groups is statistically significant (p less than 0.05). Of the 15 patients with a presplenectomy HCI of 0.7 or greater, 9 (60%) did not have a satisfactory platelet response to splenectomy, whereas of 36 patients with an HCI of 0.7 or less, only 8(22%) did not have a satisfactory platelet response to splenectomy (p less than 0.01). The HCI appears to indicate the significance of underproduction of platelets as a result of marrow replacement by hairy cells.

journal_name

Blood

journal_title

Blood

authors

Golomb HM,Vardiman JW

subject

Has Abstract

pub_date

1983-02-01 00:00:00

pages

349-52

issue

2

eissn

0006-4971

issn

1528-0020

journal_volume

61

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival.

    abstract::Recent evidence suggests chronic myeloid leukemia (CML) stem cells are insensitive to kinase inhibitors and responsible for minimal residual disease in treated patients. We investigated whether CML stem cells, in a transgenic mouse model of CML-like disease or derived from patients, are dependent on Bcr-Abl. In the tr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-326843

    authors: Hamilton A,Helgason GV,Schemionek M,Zhang B,Myssina S,Allan EK,Nicolini FE,Müller-Tidow C,Bhatia R,Brunton VG,Koschmieder S,Holyoake TL

    更新日期:2012-02-09 00:00:00

  • Myeloma bone marrow plasma cells: evidence for their capacity as antigen-presenting cells.

    abstract::Myeloma plasma cells constitute 10% to 90% of the total bone marrow cell count in patients with multiple myeloma (MM). These cells express a variety of cell surface markers, such as HLA-ABC and HLA-DR, and surface antigens that are necessary for professional antigen-presenting cells, including adhesion and costimulato...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yi Q,Dabadghao S,Osterborg A,Bergenbrant S,Holm G

    更新日期:1997-09-01 00:00:00

  • Activity of transgene-produced B-domain-deleted factor VIII in human plasma following AAV5 gene therapy.

    abstract::Adeno-associated virus (AAV)-based gene therapies can restore endogenous factor VIII (FVIII) expression in hemophilia A (HA). AAV vectors typically use a B-domain-deleted FVIII transgene, such as human FVIII-SQ in valoctocogene roxaparvovec (AAV5-FVIII-SQ). Surprisingly, the activity of transgene-produced FVIII-SQ was...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005683

    authors: Rosen S,Tiefenbacher S,Robinson M,Huang M,Srimani J,Mackenzie D,Christianson T,Pasi KJ,Rangarajan S,Symington E,Giermasz A,Pierce GF,Kim B,Zoog SJ,Vettermann C

    更新日期:2020-11-26 00:00:00

  • Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia.

    abstract::Although the graft-versus-leukemia effect of allogeneic bone marrow transplantation (BMT) is of paramount importance in the maintenance of disease remission, the role played by the autologous T-cell response in antitumor immune surveillance is less defined. We evaluated the emergence of antileukemia cytotoxic T-lympho...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2006-05-021535

    authors: Montagna D,Maccario R,Locatelli F,Montini E,Pagani S,Bonetti F,Daudt L,Turin I,Lisini D,Garavaglia C,Dellabona P,Casorati G

    更新日期:2006-12-01 00:00:00

  • Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase.

    abstract::Reduced oxygenation of a variety of cells results in transcriptional upregulation of several genes, including the hematopoietic hormone erythropoietin, the angiogenic vascular endothelial growth factor (VEGF), and glycolytic enzymes such as aldolase. Recently, the heme protein cytochrome b558 of the nicotinamide adeni...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wenger RH,Marti HH,Schuerer-Maly CC,Kvietikova I,Bauer C,Gassmann M,Maly FE

    更新日期:1996-01-15 00:00:00

  • Epidermis instructs skin homing receptor expression in human T cells.

    abstract::The localization of memory T cells to human skin is essential for long-term immune surveillance and the maintenance of barrier integrity. Although the mechanisms controlling memory T-cell migration to peripheral tissues are poorly understood, the current paradigm includes the localized secretion of "imprinting" signal...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-05-433037

    authors: McCully ML,Ladell K,Hakobyan S,Mansel RE,Price DA,Moser B

    更新日期:2012-11-29 00:00:00

  • Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells.

    abstract::Hematopoietic stem cells (HSCs) undergo dramatic expansion during fetal liver development, but attempts to expand their numbers ex vivo have failed. We hypothesized that unidentified fetal liver cells produce growth factors that support HSC proliferation. Here we describe a novel population of CD3+ and Ter119- day-15 ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-08-2955

    authors: Zhang CC,Lodish HF

    更新日期:2004-04-01 00:00:00

  • Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels.

    abstract::The t(11;14)(q13;q32) is the most common translocation in multiple myeloma (MM), resulting in up-regulation of cyclin D1. We used a segregation fluorescence in situ hybridization (FISH) assay to detect t(11;14) breakpoints in primary MM cases and real-time reverse transcriptase-polymerase chain reaction (RT-PCR) to qu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-11-3837

    authors: Specht K,Haralambieva E,Bink K,Kremer M,Mandl-Weber S,Koch I,Tomer R,Hofler H,Schuuring E,Kluin PM,Fend F,Quintanilla-Martinez L

    更新日期:2004-08-15 00:00:00

  • Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin.

    abstract::Mutations in a recently identified gene HJV (also called HFE2, or repulsive guidance molecule C, RgmC) are the major cause of juvenile hemochromatosis (JH). The protein product of HJV, hemojuvelin, contains a C-terminal glycosylphosphatidylinositol anchor, suggesting that it can be present in either a soluble or a cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-05-1845

    authors: Lin L,Goldberg YP,Ganz T

    更新日期:2005-10-15 00:00:00

  • Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities.

    abstract::We report in this paper that a novel small molecule, JTZ-132, induced growth and differentiation of megakaryocytic progenitor cells and improved thrombocytopenia in myelosuppressed mice. JTZ-132 stimulated proliferation of UT-7/TPO cells, a cell line highly sensitive to thrombopoietin (TPO), and exhibited full efficac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-10-3623

    authors: Inagaki K,Oda T,Naka Y,Shinkai H,Komatsu N,Iwamura H

    更新日期:2004-07-01 00:00:00

  • Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries.

    abstract::The pp65(495-503) cytotoxic T-lymphocyte (CTL) epitope from cytomegalovirus (CMV) is universally recognized among CMV+ individuals who express an allele of the human leukocyte antigen A (HLA-A*0201). The relative binding affinity of the epitope to HLA-A*0201 is moderate, and its increased activity might prove benefici...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.6.1776

    authors: La Rosa C,Krishnan R,Markel S,Schneck JP,Houghten R,Pinilla C,Diamond DJ

    更新日期:2001-03-15 00:00:00

  • Human HLA-specific T-cell clones with stable expression of a suicide gene: a possible tool to drive and control a graft-versus-host- graft-versus-leukemia reaction?

    abstract::Allogeneic bone marrow transplantation is still limited by the morbidity and mortality caused by graft-versus-host disease (GVHD), resulting from host recognition by donor T lymphocytes. It is possible to drastically reduce the T-cell content of the graft. However, transplanted T cells can also have a beneficial effec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gallot G,Hallet MM,Gaschet J,Moreau JF,Vivien R,Bonneville M,Milpied N,Vié H

    更新日期:1996-08-01 00:00:00

  • Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptor.

    abstract::Adoptive transfer of patient-derived T cells modified to express chimeric antigen receptors (CARTs) has demonstrated dramatic success in relapsed/refractory pre-B-cell acute lymphoblastic leukemia (ALL), but response and durability of remission requires exponential CART expansion and persistence. Tumors are known to a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-12-815548

    authors: Qin H,Ishii K,Nguyen S,Su PP,Burk CR,Kim BH,Duncan BB,Tarun S,Shah NN,Kohler ME,Fry TJ

    更新日期:2018-11-01 00:00:00

  • Culture of human fetal B-cell precursors on bone marrow stroma maintains highly proliferative CD20dim cells.

    abstract::Growth of human B-cell precursors (BCP) was achieved by plating fetal CD10+ surface-mu (s mu)- cells in liquid medium onto bone marrow-derived fibroblastic stromal cell layers deprived of hematopoietic cells. Proliferation of the fetal BCP was strongly potentiated by the addition of interleukin-7 (IL-7) to the culture...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Moreau I,Duvert V,Banchereau J,Saeland S

    更新日期:1993-03-01 00:00:00

  • Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors.

    abstract::We have analyzed the phenotype, cytokine profile, and mitotic history (telomere length) of monoclonal T-cell expansions in 5 CD3(+) T-cell large granular lymphocyte (TLGL) leukemia patients by fluorescence activated cell sorting (FACS) and single-cell polymerase chain reaction (PCR). We confirm that the common phenoty...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-08-2408

    authors: Bigouret V,Hoffmann T,Arlettaz L,Villard J,Colonna M,Ticheli A,Gratwohl A,Samii K,Chapuis B,Rufer N,Roosnek E

    更新日期:2003-04-15 00:00:00

  • Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte.

    abstract::Peroxiredoxin 2 (Prx2), a thiol-dependent peroxidase, is the third most abundant protein in the erythrocyte, and its absence in knock-out mice gives rise to hemolytic anemia. We have found that in human erythrocytes, Prx2 was extremely sensitive to oxidation by H(2)O(2), as dimerization was observed after exposure of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-048728

    authors: Low FM,Hampton MB,Peskin AV,Winterbourn CC

    更新日期:2007-03-15 00:00:00

  • How I treat venous thromboembolism in patients with cancer.

    abstract::Venous thromboembolism (VTE) is a frequent complication in cancer patients and represents an important cause of morbidity and mortality. Especially in patients who have a poor life expectancy, preventing death from pulmonary embolism is the mainstay of treatment. Critically ill patients should promptly be administered...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-04-1508

    authors: Prandoni P

    更新日期:2005-12-15 00:00:00

  • A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5.

    abstract::We report a novel t(7;9)(q11;p13) translocation in 2 patients with B-cell acute lymphoblastic leukemia (B-ALL). By fluorescent in situ hybridization and 3' rapid amplification of cDNA ends, we showed that the paired box domain of PAX5 was fused with the elastin (ELN) gene. After cloning the full-length cDNA of the chi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-025221

    authors: Bousquet M,Broccardo C,Quelen C,Meggetto F,Kuhlein E,Delsol G,Dastugue N,Brousset P

    更新日期:2007-04-15 00:00:00

  • Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia.

    abstract::High doses of recombinant factor VIIa are useful in managing bleeding in hemophiliacs with inhibitors. Whether this therapeutic effect of factor VIIa is dependent on tissue factor (TF) is a matter of debate. We examined the ability of freshly isolated human monocytes (which lack TF) to support the activation of coagul...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hoffman M,Monroe DM,Roberts HR

    更新日期:1994-01-01 00:00:00

  • Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma.

    abstract::A series of monoclonal antibodies was used for the characterization of malignant T cells from 21 patients with lymphoblastic lymphoma (LL). The tumor population from these patients showed a marked degree of phenotypic heterogeneity and a proportion (one-third) of patients had tumor cells that did not conform exactly w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bernard A,Boumsell L,Reinherz EL,Nadler LM,Ritz J,Coppin H,Richard Y,Valensi F,Dausset J,Flandrin G,Lemerle J,Schlossman SF

    更新日期:1981-06-01 00:00:00

  • High numbers of CD4+ T cells showing abnormal recognition of DR antigens in lymphoid organs involved by Hodgkin's disease.

    abstract::Purified T lymphocytes (E rosetting cells) isolated from the involved lymphoid organs (lymph nodes and spleen) of five patients with Hodgkin's disease (HD) were cloned under culture conditions (phytohemagglutinin plus interleukin-2) that allow clonal expansion of most T lymphocytes. A total number of 104 CD4+ T cell c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Maggi E,Parronchi P,Macchia D,Bellesi G,Romagnani S

    更新日期:1988-05-01 00:00:00

  • Ethical considerations in genomic testing for hematologic disorders.

    abstract::As our technological capacities improve, genomic testing is increasingly integrating into patient care. The field of clinical hematology is no exception. Genomic testing carries great promise, but several ethical issues must be considered whenever such testing is performed. This review addresses these ethical consider...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-01-734558

    authors: Marron JM,Joffe S

    更新日期:2017-07-27 00:00:00

  • Activation of hedgehog signaling associates with early disease progression in chronic lymphocytic leukemia.

    abstract::Targeted sequencing of 103 leukemia-associated genes in leukemia cells from 841 treatment-naive patients with chronic lymphocytic leukemia (CLL) identified 89 (11%) patients as having CLL cells with mutations in genes encoding proteins that putatively are involved in hedgehog (Hh) signaling. Consistent with this findi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-09-873695

    authors: Ghia EM,Rassenti LZ,Neuberg DS,Blanco A,Yousif F,Smith EN,McPherson JD,Hudson TJ,HALT Pan-Leukemia Gene Panel Consortium.,Harismendy O,Frazer KA,Kipps TJ

    更新日期:2019-06-20 00:00:00

  • Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling.

    abstract::The IFN-inducible immunity-related p47 GTPase Irgm1 has been linked to Crohn disease as well as susceptibility to tuberculosis. Previously we demonstrated that HSC quiescence and function are aberrant in mice lacking Irgm1. To investigate the molecular basis for these defects, we conducted microarray expression profil...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-328682

    authors: King KY,Baldridge MT,Weksberg DC,Chambers SM,Lukov GL,Wu S,Boles NC,Jung SY,Qin J,Liu D,Songyang Z,Eissa NT,Taylor GA,Goodell MA

    更新日期:2011-08-11 00:00:00

  • Platelet-derived VWF is not essential for normal thrombosis and hemostasis but fosters ischemic stroke injury in mice.

    abstract::Von Willebrand factor (VWF) is a key hemostatic protein synthesized in both endothelial cells and megakaryocytes. Megakaryocyte-derived VWF is stored in α-granules of platelets and is enriched in hyperactive "ultra-large" VWF multimers. To elucidate the specific contribution of platelet VWF in hemostasis and thrombosi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-03-632901

    authors: Verhenne S,Denorme F,Libbrecht S,Vandenbulcke A,Pareyn I,Deckmyn H,Lambrecht A,Nieswandt B,Kleinschnitz C,Vanhoorelbeke K,De Meyer SF

    更新日期:2015-10-01 00:00:00

  • Global gene expression analysis of human erythroid progenitors.

    abstract::Understanding the pattern of gene expression during erythropoiesis is crucial for a synthesis of erythroid developmental biology. Here, we isolated 4 distinct populations at successive erythropoietin-dependent stages of erythropoiesis, including the terminal, pyknotic stage. The transcriptome was determined using Affy...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-290825

    authors: Merryweather-Clarke AT,Atzberger A,Soneji S,Gray N,Clark K,Waugh C,McGowan SJ,Taylor S,Nandi AK,Wood WG,Roberts DJ,Higgs DR,Buckle VJ,Robson KJ

    更新日期:2011-03-31 00:00:00

  • Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.

    abstract::Heparin-induced thrombocytopenia (HIT) is caused by platelet-activating IgG antibodies that recognize platelet factor 4 (PF4) bound to heparin. Immunogenicity of heparins differs in that unfractionated heparin (UFH) induces more anti-PF4/heparin antibodies than low-molecular-weight heparin (LMWH) and UFH also causes m...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2005-05-1938

    authors: Warkentin TE,Cook RJ,Marder VJ,Sheppard JA,Moore JC,Eriksson BI,Greinacher A,Kelton JG

    更新日期:2005-12-01 00:00:00

  • CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma.

    abstract::The combination of cyclophosphamide, vincristine, and prednisone (CVP) is one of several standard treatment options for advanced follicular lymphoma. This, like similar chemotherapeutic regimens, induces response rates of 60% to 80%, with a median response duration of under 2 years. Rituximab, a chimeric monoclonal an...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2004-08-3175

    authors: Marcus R,Imrie K,Belch A,Cunningham D,Flores E,Catalano J,Solal-Celigny P,Offner F,Walewski J,Raposo J,Jack A,Smith P

    更新日期:2005-02-15 00:00:00

  • Genetic expression of adenosine deaminase in human lymphoid malignancies.

    abstract::Adenosine deaminase (ADA) is an enzyme in the purine catabolic pathway that has been used as an enzymatic marker of T cell lymphoblastic malignancies due to its high specific activity in thymocytes and immature T cells. We have investigated whether the level of ADA activity in lymphoid leukemic cells correlates with t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gan TE,Dadonna PE,Mitchell BS

    更新日期:1987-05-01 00:00:00

  • Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV.

    abstract::We describe the membrane localization of a new platelet-specific alloantigen, designated Naka, that is involved in refractoriness to HLA-matched platelet transfusions. By indirect immunoprecipitation, anti-Naka antibody precipitated a single, radiolabeled platelet membrane protein with a molecular weight (mol wt) of 9...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tomiyama Y,Take H,Ikeda H,Mitani T,Furubayashi T,Mizutani H,Yamamoto N,Tandon NN,Sekiguchi S,Jamieson GA

    更新日期:1990-02-01 00:00:00